Temporomandibular disorders (TMD) are characterized by the presence of
temporomandibular joint (TMJ) and/or masticatory muscle pain and dysfunction.
Low-level laser is presented as an adjuvant therapeutic modality for the treatment of
TMD, especially when the presence of inflammatory pain is suspected.ObjectiveTo systematically review studies that investigated the effect of low level laser
therapy (LLLT) on the pain levels in individuals with TMD. Material and MethodsThe databases Scopus, embase, ebsco and PubMed were reviewed from January/2003 to
October/2010 with the following keywords: laser therapy, low-level laser therapy,
temporomandibular joint disorders, temporomandibular joint dysfunction syndrome,
temporomandibular joint, temporomandibular, facial pain and arthralgia, with the
inclusion criteria for intervention studies in humans. exclusion criteria adopted
were intervention studies in animals, studies that were not written in english,
Spanish or Portuguese, theses, monographs, and abstracts presented in scientific
events. ResultsAfter a careful review, 14 studies fit the criteria for inclusion, of which, 12
used a placebo group. As for the protocol for laser application, the energy
density used ranged from 0.9 to 105 J/cm2, while the power density
ranged from 9.8 to 500 mW. The number of sessions varied from 1 to 20 and the
frequency of applications ranged from daily for 10 days to 1 time
per week for 4 weeks. A reduction in pain levels was reported
in 13 studies, with 9 of these occurring only in the experimental group, and 4
studies reporting pain relief for both the experimental group and for the placebo.
ConclusionMost papers showed that LLLT seemed to be effective in reducing pain from TMD.
However, the heterogeneity of the standardization regarding the parameters of
laser calls for caution in interpretation of these results. Thus, it is necessary
to conduct further research in order to obtain a consensus regarding the best
application protocol for pain relief in patients with TMD.
This study investigated the effect of low-level laser therapy (LLLT) on the masticatory performance (MP), pressure pain threshold (PPT), and pain intensity in patients with myofascial pain. Twenty-one subjects, with myofascial pain according to Research Diagnostic Criteria/temporomandibular dysfunction, were divided into laser group (n = 12) and placebo group (n = 9) to receive laser therapy (active or placebo) two times per week for 4 weeks. The measured variables were: (1) MP by analysis of the geometric mean diameter (GMD) of the chewed particles using Optocal test material, (2) PPT by a pressure algometer, and (3) pain intensity by the visual analog scale (VAS). Measurements of MP and PPT were obtained at three time points: baseline, at the end of treatment with low-level laser and 30 days after (follow-up). VAS was measured at the same times as above and weekly throughout the laser therapy. The Friedman test was used at a significance level of 5% for data analysis. The study was approved by the Ethics Committee of the Federal University of Sergipe (CAAE: 0025.0.107.000-10). A reduction in the GMD of crushed particles (p < 0.01) and an increase in PPT (p < 0.05) were seen only in the laser group when comparing the baseline and end-of-treatment values. Both groups showed a decrease in pain intensity at the end of treatment. LLLT promoted an improvement in MP and PPT of the masticatory muscles.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.